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Abstract
Chronic inflammation leads to a progressive inflammation in certain types of cells. Recent studies report that the 
activation of nuclear factor kappa B (NF-κB) increases the expression of inflammation-related protein such as inducible 
nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2), which further enhance the chronic inflammation, 
thus conduct the development of disorders. The aim of the study is to develop an efficient method for screening food 
components with anti-inflammation function. Here we employed a reporter plasmid, which contains NF-κB response 
element followed by a minimal promoter for driving the down-stream luciferase reporter gene. After transfection of this 
plasmid to a mouse cell line RAW264.7, we obtained stable clones by using Hygromycin selection. Our results reveal 
that the luciferase activity of the cell based platform can be induced by the inflammation inducing reagent LPS and 
can be further suppressed by the administration of CAPE, an anti-inflammation chemical. The results estimated by our 
platform present good correlation to that analyzed by RT-Q-PCR. Additionally, the known anti-inflammation factors 
such as resveratrol, significantly counteracted the effect of LPS on our platform. Furthermore, the screening result of 
various mushroom extract showed that some fractions revealed NF-κB activating effects. Therefore, we conclude that 
the platform is effective in large scale screening for inflammatory regulating compounds.
Key words: Inflammation, NF-κB, Luciferase assay, Cell platform
*Correspondence to:
Dr. Shu-Chen Hsieh. Graduate Institute of Food Science and Technology, National Taiwan University, No. 1, Sec. 4, Roosevelt Road, Taipei 10617, 
Taiwan, Tel: +886-2-3366-9871, Fax: +886-2-2362-0849, E-mail: scjhsieh@ntu.edu.tw
Introduction 
Chronic inflammation promotes progression of 
cardiovascular disease and  the consequent heart attack 
and stroke (Hansson and Hermansson, 2011), and 
also destroys nerve cells in the brains of Alzheimer's 
victims and facilitates the development and progression 
of cancer (Terzić et al., 2007). Recently, NF-κB has 
been reported to act as a pro-inflammatory factor in 
the development of chronic inflammation (Baker et al.,
2011). 
The stimulators of NF-κB include cytokines such 
as interleukin 1 (IL-1), tumor necrosis factor alpha 
(TNF-α), and lipopolysaccharide (LPS) (Anisowicz 
et al., 1991; Jones et al., 2007). Activated NF-κB 
plays a pivotal role in driving the expression of other 
proinflammatory genes such as cytokines, chemokines, 
and can enhance several inflammatory genes, including 
adhesion molecules, induced nitric oxide synthase 
(iNOS) and cycloxygenase-2 (COX-2).
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iNOS belongs to NOS family. As compared to 
the other two family members nNOS and eNOS, 
which exhibit constitutive expression (Huang, 2009; 
Kobayashi, 2010), the expression of iNOS is inducible 
upon many stimulus like cytokines, viruses, or LPS, 
leading to the production of large amounts of nitric 
oxide (NO). Subsequently, high concentration of NO 
causes cell proliferation, invasion (Ambs et al., 1997), 
and local or systemic inflammatory disorders (Bogdan et
al., 2000). 
COX-2, the other downstream target of NF-κB, 
catalyzes the production of Prostaglandin E2 (PGE2), 
and may function as a proinflammatory mediator 
(Dubois et al., 1998; Yang et al., 2011). 
Because the relationship between chronic diseases 
and inflammation has been well established, to find out 
compounds with anti-inflammation effects becomes 
an important issue. Typically, Western blot and RT-Q-
PCR are employed to analyze the anti-inflammation 
activity of components by detecting the expression of 
inflammation and proinflammation genes. The whole 
process is both time and money consuming. In order 
to develop a better method, we establish a cell based 
platform containing NF-κB response element fused 
reporter plasmid. We further proved that the platform 
can be used for high throughput screening for food 
components with anti-inflammation function. 
Material and methods
Cell culture and sample treatment 
RAW264.7 were grown at 37 ℃ in DMEM medium 
supplemented with 10% FBS, penicillin (100 U/ml), 
and streptomycin sulfate (100 U/ml) in a humidified 
atmosphere of 5% CO2. Cells were pretreated with 
different samples for 1 h, and followed by 1 μg/ml LPS 
(Sigma-Aldrich MO, USA) treatment for 6 h before 
luciferase assay.
Transfection and Stable clone selection
RAW264.7 cells were plated in 60 mm dish at a 
density of 90% confluence. Before transfection, the 
culture medium was replaced by serum-free DMEM 
medium for 1h, and then pGL4.32 [luc2P/NF-kB-
RE/Hyrgo (with five copies of 5 NF-κB binding 
site (GGGAA/CTTTCC); Promega, WI, USA) was 
transfected into the cells by Lipofecatime 2000 
(Invitrogen, NY, USA) according to user’s guide. The 
cells were treated with 400 μg/ml Hygromycin B for 
9 days, and 60 colonies were picked up separately for 
growing to larger amount. We further examined the 
response of each clone to LPS by luciferase assay. Only 
clones gave significant response to LPS were kept.
Assay of Luciferase activity
The cells were washed with 1X PBS buffer for three 
times, and the protein lysate was extracted by 1X lysis 
buffer according to the suggestion in the user’s guide 
(Promega, WI, USA). The cell lysates were harvested 
and followed by determining the luciferase activities 
and the total protein concentration. luciferase activities 
were measured by the Luciferase Assay System 
(Promega, WI, USA) through the procedures suggested 
in user’s guide. The total concentration of protein was 
measured by Bio-Rad Protein Assay (CA, USA), and 
the results served as an internal control to normalize the 
luminescence values.  
RNA preparation and reverse transcriptase 
polymerase chain reaction (RT-PCR)
Total cellular RNA was isolated using Tripure 
Isolation Reagent (Roche, IN, USA). For each 
sample, 2 μg of  RNA was reverse-transcribed (RT) 
using SMARTTM MMLV reverse transcriptase, 1 mM 
deoxyribonucleotide triphosphate (dNTP), 1X First-
Strand Buffer, 10 mM DTT, and 2.5 μM random 
hexamer, adjusted by DEPC H2O to the final volume 
of 20 μl in a 0.2 ml PCR tube. The tubes were then 
incubated under 42℃, 60 min for reverse transcription. 
Finally, heat at 72℃ for 15 min to inactivate the 
reaction.
Quantitative polymerase chain reaction (Q-PCR)
Q-PCR analyses were performed on aliquots of the 
cDNA preparations to detect iNOS, COX-2 and 18S (as 
an internal standard) gene expresion using a thermal 
cycler (Applied Biosystems™, CA, USA). Reactions 
were carried out in a volume of 10 μl containing 5 μl 
of 2 x of KAPA SYBR® Master Mix, 0.4 μl of 10 μM 
forward and reverse primers, 2.6 μl PCR water, and 2 
μl cDNA. After initial enzyme activation for 3 min at 
95 ℃, 40 amplification cycles were performed for three 
genes (3 sec of 95 ℃ denaturation, 20 sec of 60 ℃
annealing and extension). The PCR primers used in this 
study are listed below and were purchased from Sigma-
Aldrich (MO, USA). For gene detection of iNOS, 
sense strand: 5’-CCT GGT ACG GGC ATT GCT-3’-, 
antisense strand: 5’-GCT CAT GCG GCC TCC TTT-3’-. 
For gene detection of COX-2, sense strand: 5’-ACA 
ACA GAG TGT GCG AC-3’-, anti-sense strand: 
5’-TGA GTT TGA AGT GGT AAC CG-3’-. For gene 
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detection of 18S sense strand: 5’-TAT TCC CAT GAC 
CCG CC-3’-, anti-sense strand: 5’-GTG AGG TTT 
CCC GTG TT-3’. 
Results 
Single clone selection and confirmation of the efficacy 
of the cell based platform 
We transfected pGL4.32-NF-κB, a reporter plasmid 
containing NF-κB response element fused with the 
luciferase reporter gene, into mouse macrophage cell 
line RAW 264.7. The cells stably expressing the reporter 
plasmid survived after hygromycin selection. For the 
stable lines derived from each single colony we selected, 
we employed the luciferase assay to test whether they 
could respond to inflammation signaling. As shown in 
Figure 1A, the representative stable line we obtained 
after antibiotics selection dramatically responded to the 
inflammation signaling induced by LPS. In consistent 
with the luciferase result, the inflammation signal which 
triggered the activity of NF-κB measured in our cell 
based platform, could turn on the mRNA expression 
of iNOS and COX-2, the downstream targets of NF-
κB (Figure 1B, 1C), suggesting that our platform can 
successfully detect the inflammation signaling in culture 
environment.
Inflammation signal blocked by NF-κB inhibitor can 
be detecting by the cell based platform
After confirming the efficacy of the platform on 
sensing the inflammation signaling, we next examined 
whether the anti-inflammation signaling could be 
detected by our platform. We thus used CAPE, a NF-
κB inhibitor, to block the signaling of inflammation. 
As expected, the results revealed that the platform we 
established  was sensitive to the addition of CAPE, 
which suppressed the LPS induced luciferase activity. 
Additionally, the endogenous NF-κB activity could be 
suppressed by CAPE (Figure 2). The results together 
indicate that the platform is capable of detecting both 
inflammation and anti-inflammation signaling. 
The application of the platform for screening 
components with immune regulation activity
We further estimated the capacity of our platform 
by using a well-studied compound, resveratrol, which 
has the effects on decreasing the protein expression of 
iNOS, and COX-2 (Donnelly et al., 2004). As can be 
observed in Figure 3, the luciferase activity induced by 
LPS could be reduced by resveratrol in a dose dependent 
manner. We next tried to screen food components with 
Figure 1. The cell based platform significantly responds to the 
inflammation inducing reagent LPS. 
(A) The Raw264.7 cells stably expressing pGL4.32-NF-κB plasmid. 
were seeded in 12 well plate and grew up to the density of 70% (the 
details for constructing the cell based platform was described in 
materials and methods). After being treated with 1 μg/ml LPS for 
6 h, the total protein lysate were collected and luciferase activity 
was measured by Luminoskan Ascent. Under the same treatment as 
described in (A), the total RNA was extracted, and 2 μg RNA was 
used to be converted into cDNA, followed by Q-PCR, the mRNA 
expression of (B) iNOS and (C) COX-2 were estimated. The results 
were shown as means ±SD and analyzed by Student’s T-test to show 
the statistical significance. ** p<0.01 and * p<0.05 indicate significant 
difference when compared to control group (Ctrl).
inflammation regulating activity by using our platform. 
Mushrooms are known for the ability in regulating 
immune response; we therefore screened various 
mushroom fermentation extracts to estimate their 
immune modulating ability. As revealed in Figure 4, 
among the screening samples, the fermentation extract 
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of Ganoderma lucidum showed ability in activating 
NF-κB, consistent with the fact that compounds within 
Ganoderma lucidum  can induce moderate inflammation 
signal to enhance body defense when encountering 
pathogens (Kuo et al., 2006) 
Discussion
In this study, we have successfully established a cell 
based screening platform for searching food components 
with inflammation modulating activity. Compared with 
the traditional analyses such as Western blot and RT-
PCR, our platform can be used for high throughput 
screening because the assay system adopted in our 
platform is luciferase reporter assay. 
Reporter assay was first used in determining the gene 
expression in 1990. (Alam and Cook, 1990). In our project, 
we used pGL4.32-NF-κB to monitor the activity of NF-
κB by measuring the luciferase activity. The principle 
is that the transcription activity of NF-κB correlates to 
the expression level of reporter gene driven, hence the 
higher luciferase activity, which leads to higher amount 
of luminescent products, means higher NF-κB activity. 
Because NF-κB activity is a good marker reflecting the 
extent of inflammation, we can detect the inflammation 
signaling by reading the value of luciferase activity. 
Luciferase assay can be applied in a 96 well plate, 
and the measurement of 96 samples only takes few 
minutes, showing the efficacy for high throughput 
screening (Liu et al., 2009; Wehner et al., 2011). 
Furthermore, our cell based platform can stably express 
the reporter plasmid, implying that we don’t have to go 
through transfections before performing each luciferase 
assay. In general, before doing the reporter assay, the 
plasmid must be transfected into cells, which costs 
time and money. Especially, the transfection efficiency 
of some cell lines is low and leads to the consequent 
low sensitivity and poor assay results. For example, 
the transfection efficiency of RAW264.7 is less than 
0.5% in our preliminary test. Low level of transfection 
efficiency signifies that only few percentages of cells 
own the ability to drive reporter gene upon stimulus. 
Figure 2. The platform can monitor the anti-inflammation signal in the 
culture environment. 
The Raw264.7 cells stably expressing pGL4.32-NF-κB plasmid 
were seeded in 12 well plate and grew up to the density of 70%, then 
either pretreated with 25 μg/ml CAPE or left non-treated for 1 h and 
followed by the presence or absence of 1 μg/ml LPS treatment for 6 
h. Total protein lysates were collected and the luciferase assay was 
then taken by Luminoskan Ascent. The relative folds were shown as 
means ±SD and analyzed. ** p<0.01 and * p<0.05 reveals statistical 
significance between the samples compared using Student’s T-test.
Figure 3. The anti-inflammation effect of resveratrol can be monitored 
by the cell based platform. 
The Raw264.7 cells stably expressing pGL4.32-NF-κB plasmid 
were seeded in 12 well plate and grew up to the density of 70%, then 
the cells were pretreated with 50 or 100 μM Resveratrol for 1 h and 
then incubated with 1 μg/ml LPS for 6 h. Total protein lysates were 
collected and the luciferase activity was estimated by Luminoskan 
Ascent and results were shown as a relative fold to control with means 
±SD and analyzed by Student’s T-test to show the statistical result. 
** p<0.01 and * p<0.05 indicates the significant differences between 
samples compared.
Figure 4. The screening results of the platform. 
The Raw264.7 cells stably expressing pGL4.32-NF-κB plasmid 
were seeded in 12 well plate and grew up to the density of 70%, then 
the cells were pretreated with 100 μg/ml of the fermentation extract 
of Ganoderma lucidum 6 h respectively. Total protein lysates were 
collected and the luciferase activity was estimated by Luminoskan 
Ascent. The results show the relative fold to control. The results 
were shown as means ±SD and analyzed by Student’s T-test to show 
the statistical significance. * p<0.05 means the result of treatment is 
significant different from that of control group (Ctrl).
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In the case of RAW264.7, it could hardly respond to 
the inflammation signaling or the anti-inflammation 
signaling using transient transfection. On the contrary, 
our platform can respond to LPS and CAPE efficiently, 
indicating the application value of our platform in 
screening the food components with inflammation 
modulating ability. 
Our screening results of resveratrol and mushroom 
extract reveal that our platform can not only detect the 
anti-inflammation ability of well-studied pure compound 
identified from food resources, but also explore 
the inflammation regulating ability of extracts with 
unknown function. The results are consistent with the 
known function of resveratrol, which largely exists in 
several plants when under attack by pathogens, showing 
significant ability against inflammation (Donnelly et
al., 2004). Our results are also in agreement with the 
fact that many types of mushrooms reveal the ability to 
modulate the immune response by moderately elevating 
the inflammation level. The success of establishing a 
cell based platform demonstrates an alternative way to 
establish a time and cost saving screening platform for 
identifying components with immune regulating ability. 
In conclusion, we have established a cell based 
platform for screening anti-inflammation components 
from various food resources. The platform has 
been improved to have efficacy for high throughput 
screening and displays the potential in pharmatheutical 
application.
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